Joseph Stock

Joseph Stock is a highly experienced scientist currently serving as Principal Scientist at Novo Nordisk since January 2018, where responsibilities include leading projects focused on extra-hepatic targeting of peptide-oligonucleotide conjugates and managing CROs for siRNA and ASOs. Previously, Joseph held positions as a Scientist at Solstice Biologics, specializing in scalable synthetic schemes for linkers and siRNA conjugation, and as Senior Scientist at Pfizer (CovX), leading project chemistry for antibody-peptide conjugate programs. Initial career experience includes roles in medicinal chemistry and environmental engineering at Wyeth Ayerst Laboratories and WCI Steel, respectively. Joseph earned a Master’s degree in Organic Chemistry from Youngstown State University and a Bachelor’s degree in Chemistry and Mathematics from the University of Pittsburgh.